milatuzumab (IMMU-115) - Immunomedics
Q1 FY 2013 Results (Immunomedics) - Nov 8, 2012 - Anticipated presentation of pre-clinical data at ASH (Dec 10, 2012) 
Anticipated preclinical • Hematological Malignancies • Oncology
http://www.larvolonline.com/tlg/ccdb/ImmunomedicsQ1FY2013ResultsNov082012.pdf
 
Nov 8, 2012
 
.